Search Press releases

2 Dec 2021

UCB Announces Global Partnership to Bring Disease-Modifying Therapies to People Living with Parkinson’s Disease

Read More
30 Nov 2021

UCB and Chiesi enter global license agreement for zampilimab a novel monoclonal antibody for fibrotic lung diseases

Read More
26 Nov 2021

Disposals of own shares

Read More
19 Nov 2021

Disposals of own shares

Read More
19 Nov 2021

Positive Top-Line Results from BIMZELX®▼(bimekizumab) Phase 3 Psoriatic Arthritis Study Demonstrated Significant Improvements in Joint and Skin Symptoms

Read More
15 Nov 2021

Disposals of own shares

Read More

Stay up-to-date on the latest news and information from UCB